Hansa Biopharma Ab Stock Profit Margin
| HNSA Stock | SEK 23.60 0.08 0.34% |
Hansa Biopharma AB fundamentals help investors to digest information that contributes to Hansa Biopharma's financial success or failures. It also enables traders to predict the movement of Hansa Stock. The fundamental analysis module provides a way to measure Hansa Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hansa Biopharma stock.
Hansa |
Hansa Biopharma AB Company Profit Margin Analysis
Hansa Biopharma's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Hansa Biopharma AB has a Profit Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The profit margin for all Sweden stocks is 100.0% lower than that of the firm.
Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Hansa Fundamentals
| Return On Equity | -0.89 | |||
| Return On Asset | -0.27 | |||
| Operating Margin | (3.80) % | |||
| Current Valuation | 2.17 B | |||
| Shares Outstanding | 52.44 M | |||
| Shares Owned By Insiders | 7.37 % | |||
| Shares Owned By Institutions | 41.33 % | |||
| Price To Book | 7.52 X | |||
| Price To Sales | 17.67 X | |||
| Revenue | 154.53 M | |||
| Gross Profit | 116.05 M | |||
| EBITDA | (585.52 M) | |||
| Net Income | (609.57 M) | |||
| Cash And Equivalents | 762.73 M | |||
| Cash Per Share | 19.06 X | |||
| Total Debt | 783.93 M | |||
| Debt To Equity | 1.60 % | |||
| Current Ratio | 15.45 X | |||
| Book Value Per Share | 11.55 X | |||
| Cash Flow From Operations | (504.36 M) | |||
| Earnings Per Share | (13.10) X | |||
| Target Price | 171.0 | |||
| Number Of Employees | 150 | |||
| Beta | 0.88 | |||
| Market Capitalization | 2.82 B | |||
| Total Asset | 1.69 B | |||
| Z Score | 1.8 | |||
| Net Asset | 1.69 B |
About Hansa Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hansa Biopharma AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hansa Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hansa Biopharma AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Hansa Stock Analysis
When running Hansa Biopharma's price analysis, check to measure Hansa Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hansa Biopharma is operating at the current time. Most of Hansa Biopharma's value examination focuses on studying past and present price action to predict the probability of Hansa Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hansa Biopharma's price. Additionally, you may evaluate how the addition of Hansa Biopharma to your portfolios can decrease your overall portfolio volatility.